TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.
about
Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B.Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis.The decreased expression of TIPE2 protein in the decidua of patients with missed abortion and possible significance.The extracellular vesicles secreted by lung cancer cells in radiation therapy promote endothelial cell angiogenesis by transferring miR-23a.Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway.Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization.Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation.TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway.The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cellsTIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC)
P2860
Q33761546-3F0929F1-57A4-440F-90DD-A5CC225DADFBQ38598362-8F7911A0-5585-440D-8B72-88D72AC81E6AQ38603360-D6809D03-2CBB-4D1F-89AD-313E4B018969Q41531104-A692EB88-F69A-4519-95E9-7AEF3BDEF3C6Q46763062-F10F32BC-B3A1-4483-A2B4-6CE146499FAEQ47135523-D6B71642-1FAA-4966-BCB9-E21A36E7F813Q47652910-FEE3647D-79FB-43DB-B95C-7DBF9E0BA0E4Q52724791-704CB4D4-E91F-47F4-8D79-645583A5EA9FQ55311780-E6053232-7277-465E-9FD0-BBBD4C6E9A30Q58694995-380D3CBD-7553-437A-B35C-6E70A4B51F02Q58782084-64A2EDF8-8135-4BBA-9BDB-57306400AD36
P2860
TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TIPE2 suppresses angiogenesis ...... ctivation and VEGF expression.
@en
TIPE2 suppresses angiogenesis and non-small cell lung cancer
@nl
type
label
TIPE2 suppresses angiogenesis ...... ctivation and VEGF expression.
@en
TIPE2 suppresses angiogenesis and non-small cell lung cancer
@nl
prefLabel
TIPE2 suppresses angiogenesis ...... ctivation and VEGF expression.
@en
TIPE2 suppresses angiogenesis and non-small cell lung cancer
@nl
P2093
P2860
P356
P1433
P1476
TIPE2 suppresses angiogenesis ...... activation and VEGF expression
@en
P2093
Chengjun Zhou
Faliang Zhu
Jianing Wang
Lining Zhang
Xianglan Liu
Xiaoyan Wang
Yongyu Shi
P2860
P304
62224-62239
P356
10.18632/ONCOTARGET.11406
P407
P50
P577
2016-09-01T00:00:00Z